Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion

Breast

Volumn 16, Issue 2, 2007, Pages 146-151

  Zavagno, Giorgio ^a   Belardinelli, Valentina ^a   Marconato, Renato ^b   Carcoforo, Paolo ^c   Franchini, Zeno ^d   Scalco, Giuliano ^e   Burelli, Paolo ^f   Pietrarota, Paolo ^d   Mencarelli, Roberto ^a   Marconato, Giorgia ^a   Nitti, Donato ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Hospital Venezia Mestre   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d BORGO TRENTO HOSPITAL   (Italy)

^e Hospital of Vicenza   (Italy)

^f Hospital of Conegliano   (Italy)

Author keywords

Axillary lymph node dissection; Ductal carcinoma in situ; Lymph node metastasis; Microinvasion; Sentinel lymph node biopsy

Indexed keywords

EOSIN; HEMATOXYLIN; NANOCOLL; NANOCOLL TC 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BASEMENT MEMBRANE; CARCINOMA IN SITU; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MASTECTOMY; MICROMETASTASIS; PREVALENCE; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY;

EID: 33947638528     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2006.08.002     Document Type: Article

References (26)

1. American Joint Committee on Cancer. Cancer staging manual. 5th ed (2002), Springer, Berlin p 261
2. Silver S.A., and Tavassoli F.A. Mammary ductal carcinoma in situ with microinvasion. Cancer 82 (1998) 2382-2390
3. World Health Organization. Pathology and genetics of tumours of the breast and female genital organs (2003), IARC Press, Lyon p. 74-5
4. Rosen P.P. Rosen's breast pathology. 2nd ed (2001), Lippincott, Williams &Wilkins Publishers, Philadelphia p. 257-323
5. Holland R., Peterse J.L., Millis R.R., et al. Ductal carcinoma in situ: proposal for a new classification. Semin Diagn Pathol 11 (1994) 167-180
6. Zavagno G., Busolin R., Bozza F., et al. Sentinel node biopsy in breast cancer. Breast 9 (2000) 139-143
7. Wong J.H., Kopald K.H., and Morton D.L. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 125 (1990) 1298-1302
8. Rosner D., Lane W.W., and Penetrante R. Ductal carcinoma in situ with microinvasion. Cancer 67 (1991) 1498-1503
9. Jimenez R.E., and Visscher D.W. Clinicopathologic analysis of microscopically invasive breast carcinoma. Hum Pathol 29 (1998) 1412-1419
10. Le Bouëdec G., Penault-Llorca F., de Latour M., et al. Carcinome canalaire micro-invasif du sein. Place du curage ganglionnaire axillaire. Gynecol Obstet Biol Reprod 28 (1999) 10-16
11. Zavotsky J., Hansen N., Brennan M.B., Turner R.R., and Giuliano A.E. Lymph node metastasis from ductal carcinoma in situ with microinvasion. Cancer 85 (1999) 2439-2443
12. Padmore R.F., Fowble B., Hoffman J., Rosser C., Hanlon A., and Patchefsky A.S. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience. Cancer 88 (2000) 1403-1409
13. Klauber-DeMore N., Tan L.K., Liberman L., et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?. Ann Surg Oncol 7 (2000) 636-642
14. Wasserberg N., Morgenstern S., Schachter J., Fenig E., Lelcuk S., and Gutman H. Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component. Arch Surg 137 (2002) 1249-1252
15. Yang M., Moriya T., Oguma M., et al. Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases. Pathol Int 53 (2003) 422-428
16. Intra M., Zurrida S., Maffini F., et al. Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol 10 (2003) 1160-1165
17. Le Bouëdec G., Gimbergues P., Feillel V., Penault-Llorca F., and Dauplat J. Cancers canalaires in situ du sein avec micro-invasion. Quelle exploration ganglionnaire axillaire?. Presse Med 34 (2005) 208-212
18. Zavagno G., Carcoforo P., Marconato R., et al. Role of axillary sentinel node biopsy in patient with pure ductal carcinoma in situ of the breast. BMC Cancer 5 (2005) 28-34
19. Kelly T.A., Kim J.A., Patrik R., Grundfest S., and Crowe J.P. Axillary lymph node metastases in patient with a final diagnosis of ductal carcinoma in situ. Am J Surg 186 (2003) 368-370
20. Intra M., Veronesi P., Mazzarol G., et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 138 (2003) 309-313
21. Farkas E.A., Stolier A.J., Teng S.C., Bolton J.S., and Fuhrman G.M. An argument against routine sentinel node mapping for DCIS. Am Surg 70 (2004) 13-18
22. Sener S.F., Winchester D.J., Martz C.H., et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92 (2001) 748-752
23. Mansel R.E., Fallowfield L., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98 (2006) 599-609
24. Wong S.L., Edwards M.J., Chao C., et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol 9 (2002) 272-277
25. Schwartz G.F., Giuliano A.E., and Veronesi U. The Consensus Conference Committee: proceedings of the Consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22 2001, Philadelphia, PA, USA. Breast J 8 (2002) 126-138
26. Zavagno G., De Salvo G.L., Bozza F., et al. Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer. Breast Cancer Res Treat 86 (2004) 171-179